Published
At this meeting, the committee will discuss the safety and efficacy of biologics license application (BLA) 761326 for NNC0148-0287 injection (insulin icodec), a long-acting insulin analog product, submitted by Novo Nordisk. The proposed indication is to improve glycemic control in adults with diabetes mellitus.
- Category
- Management
Be the first to comment
-
2:49:56
2024 06 06 Investor Advisory Committee Meeting Public Meeting Part 02
-
8:12:21
Meeting of the Cardiovascular and Renal Drugs Advisory Committee (CRDAC)
-
7:02:20
Census National Advisory Committee - 2024 Spring Meeting: May 2, 2024
-
6:04:50
Oncologic Drugs Advisory Committee Meeting
-
9:05:10
October 31, 2024 Endocrinologic and Metabolic Drugs Advisory Committee
-
9:08:15
March 15, 2024 Meeting of the Oncologic Drugs Advisory Committee (ODAC)
-
6:49:31
April 12, 2024 Meeting of the Oncologic Drugs Advisory Committee (ODAC)
-
8:30:00
August 2, 2024 Meeting of the Genetic Metabolic Diseases Advisory Committee (GeMDAC)
-
1:10:43
27th Bi-Annual CDC/ATSDR Tribal Advisory Committee Meeting, February 22, 2024. Part 1
-
8:34:46
March 5, 2024 Meeting of the Medical Imaging Drugs Advisory Committee (MIDAC)
-
03:29
Deca Roleplay Video - Lily Papadakis (Marshall) (Business Management)
-
00:20
motivational video for libasna ll inspiration for upsc aspirants ll #short #upse #amitabhbachchan
-
17:46
FreeStyle Libre 3 vs Dexcom G6 | Full Test & Review
-
09:59
Learn Communication Skills | English Speaking | Management Insight #7
-
1:43:58
How to Trade In Stocks By: Jesse Livermore. Complete Audiobook.
-
06:52
Three Questions to Ask Yourself To Be a Great Leader
-
07:35
find your unique style | Style Roots QUIZ + body types
